News and updates in the research and development of digital biomarkers and wearable sensor technologies.


March 3-6, 2024

MDA 2024 Clinical & Scientific Conference

Orlando, FL
MDA is the #1 health nonprofit advancing research, care, and advocacy for people living with muscular dystrophy, ALS, and related neuromuscular diseases.

April 13 - 18

American Academy Neurology 2024

Denver, CO
The AAN Annual Meeting is the largest gathering of neurologists and neuroscience professionals and offers top-tier education, the latest in scientific discoveries, and an abundance of opportunities to connect with friends and colleagues from around the globe.

June 16 - 20 2024

DIA 2024 Global Annual Meeting

San Diego, CA
The 60th Anniversary of the DIA Global Annual Meeting invites industry, regulatory government, academics, and patients to network, problem-solve, and discuss global and local challenges facing the life sciences community.


April 13, 2023

BioDigit Speech: Integrated Speech Collection and Biomarker Analysis Technology

BioSensics is pleased to announce the launch of BioDigit Speech, a state-of-the-art solution for speech data collection and analysis.
Read more

March 24, 2023

Introducing Nili - An Innovative Digital Health Solution for Caregivers

Nili is a digital health solution designed to support the needs of seniors and patients, while minimizing the burden of caregiving.
Read more

March 14, 2023

2023 MDA Clinical & Scientific Conference

BioSensics is excited to sponsor and attend the 2023 MDA Clinical & Scientific Conference next week in Dallas, TX (Booth #730).
Read more

January 24, 2023

$2.5M NIH Award to Develop a Multi-Modal Remote Monitoring Solution for FTLD Syndromes

BioSensics is pleased to announce a $2.5M/2-year award from the U.S. National Institute of Health (NIH) to develop a robust multi-modal solution for remote monitoring of motor, speech, and cognitive function in Frontotemporal lobar degeneration (FTLD) syndromes.
Read more

November 30, 2022

NIH Selects BioSensics to Develop Remote Measurement Technologies for Rare Diseases

BioSensics has been selected by the U.S. National Institute of Health to develop remote measurement technologies for use in clinical trials in individuals with rare diseases.
Read more